Modulation of synaptic maintenance
US-2015368324-A1 · Dec 24, 2015 · US
Method for the prevention and treatment of sepsis
US9155756B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9155756-B2 |
| Application number | US-201214131016-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 12, 2012 |
| Priority date | Jul 14, 2011 |
| Publication date | Oct 13, 2015 |
| Grant date | Oct 13, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
This invention is in the field of medical treatment, in particular the invention provides a method for the prevention and treatment for sepsis or septic shock. The invention provides a novel use of a known medicament, i.e., pentasaccharide-depleted heparin, for use in the treatment or prevention of sepsis, systemic inflammatory response syndrome, severe sepsis or septic shock.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for the treatment of a subject suffering from sepsis, systemic inflammatory response syndrome, severe sepsis, or septic shock, the method comprising: administering a pentasaccharide-depleted fraction of natural heparin to the subject. 2. The method according to claim 1 , wherein the subject is suffering from systemic inflammatory response syndrome. 3. The method according to claim 1 , wherein the sub…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K31/727Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9155756B2 cover?
- This invention is in the field of medical treatment, in particular the invention provides a method for the prevention and treatment for sepsis or septic shock. The invention provides a novel use of a known medicament, i.e., pentasaccharide-depleted heparin, for use in the treatment or prevention of sepsis, systemic inflammatory response syndrome, severe sepsis or septic shock.
- Who is the assignee on this patent?
- Nicolaes Gerardus Anna Franciscus, Reutelingsperger Christiaan Peter Maria, Hemker Hendrik Coenraad, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification A61K31/727. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).